References
- Spanagel R. Alcoholism: A systems approach from molecular physiology to addictive behavior. Physiol Rev. 2009;89:649–705.
- Weissbach A, Werner E, Bally JF, et al. Alcohol improves cerebellar learning deficit in myoclonus–dystonia: A clinical and electrophysiological investigation. Ann Neurol. 2017;82:543–553.
- Ding W, Li M, Chen X, et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology. 2010;139:1740–1752.
- Walter TJ, Crews FT. Microglial depletion alters the brain neuroimmune response to acute binge ethanol withdrawal. J Neuroinflammation. 2017;14:1–19.
- Lippai D, Bala S, Csak T, et al. Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in Mice. PLoS One. 2013;8:1–10.
- Meisel RL, Behav H, Sci ANYA, et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science. 2000;80(287):1056–1060.
- Freund G. Apoptosis and gene expression: perspectives on alcohol-induced brain damage. Alcohol. 1994;11:385–387.
- Jung ME, Gatch MB, Simpkins JW. Estrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: potential mechanisms. Exp Biol Med. 2005;230:8–22.
- Chen W, Hu Y, Ju DW. Gene therapy for neurodegenerative disorders: advances, insights and prospects. Acta Pharm Sin B. 2020. DOI:10.1016/j.apsb.2020.01.015
- Lai AY, McLaurin JA. Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer’s disease. J Neurochem. 2018;144:659–668.
- Liu J, Gao H-Y, Wang X-F. The role of the Rho/ROCK signaling pathway in inhibiting axonal regeneration in the central nervous system. Neural Regen Res. 2015;10:1892–1896.
- Forgione N, Fehlings MG. Rho-ROCK inhibition in the treatment of spinal cord injury. World Neurosurg. 2014;82:E535–E539.
- Huentelman MJ, Stephan DA, Talboom J, et al. Peripheral delivery of a ROCK Inhibitor Improves Learning And Working Memory. Behav Neurosci. 2009;123:218–223.
- Song Y, Chen X, Wang LY, et al. Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats. CNS Neurosci Ther. 2013;19:603–610.
- Shibuya M, Hirai S, Seto M, et al. Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci. 2005;238:31–39.
- Nakagawa O, Fujisawa K, Ishizaki T, et al. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 1996;392:189–193.
- Liu Y, Zhang Y, Peng J, et al. Autophagy alleviates ethanol-induced memory impairment in association with anti-apoptotic and anti-inflammatory pathways. Brain Behav Immun. 2019;82:63–75.
- Wang P, Luo Q, Qiao H, et al. The neuroprotective effects of carvacrol on ethanol-induced hippocampal neurons impairment via the antioxidative and antiapoptotic pathways. Oxid Med Cell Longev. 2017;2017:4079425.
- Das S, Kumar M, Negi V, et al. MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2014;50:882–892.
- Clark RSB, Kochanek PM, Watkins SC, et al. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem. 2000;74:740–753.
- Bai X, Fan L, He T, et al. SIRT1 protects rat lung tissue against severe burn-induced remote ALI by attenuating the apoptosis of PMVECs via p38 MAPK signaling. Sci Rep. 2015;5:1–13.
- Zhao Q, Wu X, Yan S, et al. The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes. J Neuroinflammation. 2016;13:1–17.
- Koch JC, Tönges L, Barski E, et al. ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS. Cell Death Dis. 2014;5:1–12.
- Yang X, Liu Y, Liu C, et al. Inhibition of ROCK2 expression protects against methamphetamine-induced neurotoxicity in PC12 cells. Brain Res. 2013;1533:16–25.
- Si W, Ye S, Ren Z, et al. miR335 promotes stress granule formation to inhibit apoptosis by targeting ROCK2 in acute ischemic stroke. Int J Mol Med. 2019;43(1452–14665). DOI:10.3892/ijmm.2019.4073
- Ding H, Gao S, Wang L, et al. Overexpression of miR-582-5p inhibits the apoptosis of neuronal cells after cerebral ischemic stroke through regulating PAR-1/Rho/Rho axis. J Stroke Cerebrovasc Dis. 2019;28:149–155.
- Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med. 2004;10:S18–S25.
- Kumral A, Tugyan K, Gonenc S, et al. Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res. 2005; 160:146–156.
- Das SK, Hiran KR, Mukherjee S, et al. Oxidative stress is the primary event: effects of ethanol consumption in brain. Indian J Clin Biochem. 2007;22:99–104.
- Ku BM, Lee YK, Jeong JY, et al. Ethanol-induced oxidative stress is mediated by p38 MAPK pathway in mouse hippocampal cells. Neurosci Lett. 2007;419:64–67.
- Matthews DB, Morrow AL. Effects of acute and chronic ethanol exposure on spatial cognitive processing and hippocampal function in the rat. Hippocampus. 2000;10:122–130.
- Ward RJ, Lallemand F, de Witte P, et al. Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson’s disease: potential targets for the development of new therapeutic agents. Prog Neurobiol. 2008;85:135–147.
- Castillo J, Moro MÁ, Blanco M, et al. The release of tumor necrosis factor-α is associated with ischemic tolerance in human stroke. Ann Neurol. 2003;54:811–819.
- Strle K, Zhou JH, Shen WH, et al. Interleukin-10 in the brain. Crit Rev Immunol. 2001;21:427–449.
- Vallières L, Rivest S. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology. 1999;140:3890–3903.
- Mong PY, Wang Q. Activation of Rho kinase isoforms in lung endothelial cells during inflammation. J Immunol. 2009;182:2385–2394.
- Yang W, Zhou G, Yu T, et al. Critical role of ROCK2 activity in facilitating mucosal CD4+ T cell activation in inflammatory bowel disease. J Autoimmun. 2018;89:125–138.
- Zhu Y, Culmsee C, Klumpp S, et al. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience. 2004;123:897–906.
- Neurath MF, Pettersson S, Meyer Zum Buschenfelde KH, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996;2:998–1004.
- Nonaka M, Chen XH, Pierce JE, et al. Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma. 1999;16:1023–1034.
- Lezoualc’h F, Behl C. Transcription factor NF-kappaB: friend or foe of neurons? Mol Psychiatry. 1998;3:15–20.
- Lee SJ, Park JY, Hou J, et al. Transcriptional regulation of the intercellular adhesion molecule-1 gene by proinflammatory cytokines in human astrocytes. Glia. 1999;25:21–32.
- Sullivan PG, Bruce-Keller AJ, Rabchevsky AG, et al. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci. 1999;19:6248–6256.
- Nozaki Y, Kinoshita K, Hino S, et al. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity. Am J Physiol - Ren Physiol. 2015;308:F899–F909.
- Henderson BW, Greathouse KM, Ramdas R, et al. Pharmacologic inhibition of LIMK1 provides dendritic spine resilience against beta-amyloid. Sci Signal. 2019;12:eaaw9318.
- Koch JC, Tonges L, Barski E, et al. ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS. Cell Death Dis. 2014;5:e1225.
- Saal KA, Koch JC, Tatenhorst L, et al. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson’s disease in vitro and in vivo. Neurobiol Dis. 2015;73:150–162.